<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_APSB1713 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEga1 jpg ?><?FILEmmc1 pdf ?><?FILEsc1 jpg ?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Pharm Sin B</journal-id><journal-id journal-id-type="iso-abbrev">Acta Pharm Sin B</journal-id><journal-title-group><journal-title>Acta Pharmaceutica Sinica. B</journal-title></journal-title-group><issn pub-type="ppub">2211-3835</issn><issn pub-type="epub">2211-3843</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10501868</article-id><article-id pub-id-type="pii">S2211-3835(23)00199-5</article-id><article-id pub-id-type="doi">10.1016/j.apsb.2023.05.036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Characterization of the depsidone gene cluster reveals etherification, decarboxylation and multiple halogenations as tailoring steps in depsidone assembly</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Yang</surname><given-names>Jiafan</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Zhou</surname><given-names>Zhenbin</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Chen</surname><given-names>Yingying</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Song</surname><given-names>Yongxiang</given-names></name><email>songx@scsio.ac.cn</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Ju</surname><given-names>Jianhua</given-names></name><email>jju@scsio.ac.cn</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>a</label>CAS Key Laboratory of Tropical Marine Bio-resources and Ecology, RNAM Center for Marine Microbiology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, China</aff><aff id="aff2"><label>b</label>University of Chinese Academy of Sciences, Beijing 110039, China</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding authors. <email>songx@scsio.ac.cn</email><email>jju@scsio.ac.cn</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>01</day><month>6</month><year>2023</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>9</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>6</month><year>2023</year></pub-date><volume>13</volume><issue>9</issue><fpage>3919</fpage><lpage>3929</lpage><history><date date-type="received"><day>13</day><month>2</month><year>2023</year></date><date date-type="rev-recd"><day>17</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>12</day><month>5</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>Depsides and depsidones have attracted attention for biosynthetic studies due to their broad biological activities and structural diversity. Previous structure&#x02012;activity relationships indicated that triple halogenated depsidones display the best anti-pathogenic activity. However, the gene cluster and the tailoring steps responsible for halogenated depsidone nornidulin (<bold>3</bold>) remain enigmatic. In this study, we disclosed the complete biosynthetic pathway of the halogenated depsidone through <italic>in&#x000a0;vivo</italic> gene disruption, heterologous expression and <italic>in&#x000a0;vitro</italic> biochemical experiments. We demonstrated an unusual depside skeleton biosynthesis process mediated by both highly-reducing polyketide synthase and non-reducing polyketide synthase, which is distinct from the common depside skeleton biosynthesis. This skeleton was subsequently modified by two in-cluster enzymes DepG and DepF for the ether bond formation and decarboxylation, respectively. In addition, the decarboxylase DepF exhibited substrate promiscuity for different scaffold substrates. Finally, and interestingly, we discovered a halogenase encoded remotely from the biosynthetic gene cluster, which catalyzes triple-halogenation to produce the active end product nornidulin (<bold>3</bold>). These discoveries provide new insights for further understanding the biosynthesis of depsidones and their derivatives.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><p>A new and concise biosynthetic pathway of nornidulin (<bold>3</bold>) was elucidated. The depside skeleton <bold>2</bold> is synthesized by a collaborating hrPKS and nrPKS pair, followed by etherification, decarboxylation and halogenation.<fig id="undfig1" position="anchor"><alt-text id="alttext0010">Image 1</alt-text><graphic xlink:href="ga1"/></fig></p></abstract><kwd-group id="kwrds0010"><title>Key words</title><kwd>Depside and depsidone</kwd><kwd>Polyketide synthase</kwd><kwd>Tailoring enzymes</kwd><kwd>Multiple-halogenated</kwd><kwd>Antibacterial activity</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">Depsidones and depsides (DEPs) are the classic natural products widely produced by fungi, lichens, and plants<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref>. To date, more than 100 DEPs have been reported and exhibited extensively varying bioactivities such as anti-microbial, anti-tumor, anti-oxidant, anti-virus, and enzyme inhibitor activities<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>. DEPs consist of two 2,4-dihydroxybenzoic acid rings linked to each other by both ether and ester bonds. They are usually highly halogenated in fungi, which is one means by which DEPs chemical diversity is enriched. Previously structure&#x02012;activity relationships (SARs) showed that the anti-infective activities of the highly halogenated depsidones (nornidulin (<bold>3</bold>) and emeguisin A (<bold>10</bold>)) are much stronger than the depside precursors (agonodepside A (<bold>1</bold>) and unguidepside A (<bold>2</bold>))<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). Although the first depsidone, nidulin (<bold>4</bold>), has been reported in 1949<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref>, the biosynthetic gene clusters (BGCs) and detailed tailoring enzymes responsible for generating these interesting bioactive compounds in fungi have not yet been elucidated.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Compounds <bold>1</bold>&#x02212;<bold>16</bold> were previously isolated from the <italic>Aspergillus</italic> sp. SCSIO SX7S7<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref>. Compounds <bold>17</bold>&#x02013;<bold>22</bold> were isolated in this study from its mutants. The new compounds were marked in red. Compound <bold>23</bold> was detected by LC&#x02012;MS analysis.</p></caption><alt-text id="alttext0020">Figure&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig></p><p id="p0015">Initiatives to understand DEPs and related biosynthetic machineries have lagged far behind the discovery of their analogues and semi-synthetic approaches to chemical derivatives<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib14" ref-type="bibr"><sup>14</sup></xref>. It was not until 2018 that Andrew M. Piggott and co-workers<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> conducted a precursor-directed biosynthesis of depsidones. These studies were inspired by their hypothesis that DEPs biosynthesis employs a single polyketide synthase (PKS) that carries out the assembly of the acyclic core scaffold and converges the two aromatic rings to yield a depside. Recently, three interesting biosynthesis cases for depside skeleton assembly have been elucidated in fungi (<xref rid="sch1" ref-type="fig">Scheme 1</xref>, Routes A&#x02012;C)<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>. Notably, all of them need only one non-reducing polyketide synthase (nrPKS). Unusually, in routes A and B, the depside bond formation is proved to be catalyzed by the starter-unit acyltransferase (SAT) domain (<xref rid="sch1" ref-type="fig">Scheme 1</xref>, Routes A&#x02012;B)<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="bib12" ref-type="bibr"><sup>12</sup></xref>. However, it is still unclear how unguidepside A (<bold>2</bold>) converts to nornidulin (<bold>3</bold>), and whether the multiple halogenated in DEPs is catalyzed by one or multiple enzymes. Identifying novel tailoring enzymes from nature is vital for generating novel bioactive compounds <italic>via</italic> metabolic engineering to modify the biosynthetic pathways for drug development<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref>. Thus, further characterization of tailoring enzymes during DEPs assembly would boost our understanding of the biosynthetic pathway of this vital natural product family. In this study, we discovered that the bicyclic depside skeleton formation in DEPs involved two PKSs (<xref rid="sch1" ref-type="fig">Scheme 1</xref>, Route D). In addition, the tailoring steps of etherification, decarboxylation, and multiple halogenations of DEPs were also investigated in <italic>Aspergillus</italic> sp. SCSIO SX7S7.<fig id="sch1"><label>Scheme 1</label><caption><p>Biosynthetic models for depside formation. Routes A&#x02012;C are previously reported cases in which the depside skeleton was formed by a single PKS<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>. Route D is the proposed formation of precursors <bold>2</bold> and <bold>23</bold> in this study, compound <bold>2</bold> was formed by two PKSs.</p></caption><alt-text id="alttext0045">Scheme 1</alt-text><graphic xlink:href="sc1"/></fig></p></sec><sec id="sec2"><label>2</label><title>Results and discussion</title><sec id="sec2.1"><label>2.1</label><title>Identification of the dep gene cluster unveils the formation of precursor unguidepside A (<bold>2</bold>) requiring both hrPKS and nrPKS</title><p id="p0020">In our previous chemical investigations, a series of tricyclic depsidones and bicyclic depsides were obtained from the coral-derived fungus <italic>Aspergillus</italic> sp. SCSIO SX7S7 (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>)<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref>. The SARs analyses showed that the existence of the heptacyclic ring is crucial to anti-pathogen activities and that tailoring steps such as decarboxylation and multiple halogenation can enhance antimicrobial activities<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref>.</p><p id="p0025">To clarify the biosynthetic production mechanisms affording DEPs, whole-genome sequencing of <italic>Aspergillus</italic> sp. SCSIO SX7S7 was performed using Illumina technology and assembled into a total of 53 scaffolds (&#x0223c;26.6&#x000a0;Mb in size). AntiSMASH analyses<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> showed that the genome of SCSIO SX7S7 encodes at least 49 secondary metabolite (SM) BGCs, including 6 highly reducing polyketide synthases (hrPKS), 4 nrPKS, and 2 nrPKS and hrPKS hybrid BGCs (Supporting Information <xref rid="appsec1" ref-type="sec">Table S1</xref>). Bioinformatically, the nrPKS of hybrid BGC in scaffold 11 showed 51% identical to Preu6 which was responsible for lecanoric acid (<bold>23</bold>) (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>, <xref rid="sch1" ref-type="fig">Scheme 1</xref>, Route B)<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref>. However, other candidate PKSs do not have the potential to produce DEPs based on the homology analysis (<xref rid="appsec1" ref-type="sec">Table S1</xref>). Meanwhile, in this hybrid BGC (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>A), the domain architecture of hrPKS (DepD) is ketosynthase (KS)-acyltransferase (AT)-dehydratase (DH)-<italic>C</italic>-methyltransferase (cMT)-enoylreductase (ER)-ketoreductase (KR)-acyl carrier protein (ACP). Moreover, the nrPKS (DepH) contains a domain architecture of SAT-KS-AT-PT (Product Template)-cMT-TE. To critically evaluate the BGCs of interest, we inactivated the possible nrPKS distributed in the scaffold 11 based on our previously reported CRISPR-Cas9 gene disruption system to identify the key enzymes responsible for constructing the DEPs skeleton<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref>. Expectedly, inactivation of the nrPKS (<italic>depH</italic>) in scaffold 11 completely abolished the production of DEPs (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>B, v). Thus, we reasoned that the <italic>depH</italic>-containing cluster is responsible for DEP biosynthesis in <italic>Aspergillus</italic> sp. SCSIO SX7S7 (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>A). Accordingly, this cluster was designated as the <italic>dep</italic> cluster, and subsequent studies revealed that it contains 15 genes altogether (deposited as GenBank accession number OP889148, <xref rid="tbl1" ref-type="table">Table 1</xref>). Another hrPKS gene, <italic>depD</italic>, was further inactivated, and as expected, the mutant strain failed to accumulate any DEPs (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>B, ii).<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>The deduced functions of ORFs from the <italic>dep</italic> gene cluster in SCSIO SX7S7.</p></caption><alt-text id="alttext0050">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th><italic>Orfs</italic></th><th>Proposed function, origin</th><th>ID/SI<xref rid="tbl1fna" ref-type="table-fn">a</xref></th><th>Protein homologue and origin</th></tr></thead><tbody><tr><td><italic>&#x02212;2</italic></td><td>Serine/threonine kinase, Vhs1</td><td>36/51</td><td>(Q03785.1): <italic>Saccharomyces cerevisiae</italic> S288C</td></tr><tr><td><italic>&#x02212;1</italic></td><td>Putative protein</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td><italic>depA</italic></td><td>Serine/threonine kinase, Prp4</td><td>71/78</td><td>(Q07538.2): <italic>Schizosaccharomyces pombe</italic> 972&#x000a0;h-</td></tr><tr><td><italic>depB</italic></td><td>Translation machinery-associated protein</td><td>58/77</td><td>(Q4SUE2.1): <italic>Tetraodon nigroviridis</italic></td></tr><tr><td><italic>depC</italic></td><td>Putative protein</td><td>66/74</td><td>(XP_026605900.1): <italic>Aspergillus mulundensis</italic></td></tr><tr><td><italic>depD</italic></td><td>HrPKS, CdmE (KS-AT-DH-cMT-ER-KR-ACP)</td><td>32/50</td><td>(A0A3G9GQ29.1): <italic>Talaromyces verruculosus</italic></td></tr><tr><td><italic>depE</italic></td><td>Putative protein</td><td>49/62</td><td>(XP_025519284.1): <italic>Aspergillus piperis</italic> CBS 112811</td></tr><tr><td><italic>depF</italic></td><td>Decarboxylase, YanB</td><td>37/54</td><td>(G3Y417.1): <italic>Aspergillus niger</italic> ATCC 1015</td></tr><tr><td><italic>depG</italic></td><td>Cytochrome P450 monooxygenase, Atr2</td><td>33/52</td><td>(A0A8F4SN83.1): <italic>Stereocaulon alpinum</italic></td></tr><tr><td><italic>depH</italic></td><td>NrPKS, Preu6(SAT-KS-AT-PT-MT-ACP-TE)</td><td>51/67</td><td>(P9WET2.1): <italic>Preussia isomera</italic></td></tr><tr><td><italic>depI</italic></td><td>Putative protein</td><td>55/70</td><td>(XP_035339546.1): <italic>Talaromyces rugulosus</italic></td></tr><tr><td><italic>depJ</italic></td><td>Dioxygenase</td><td>36/49</td><td>(P31019.1): <italic>Pseudomonas</italic> sp. EST1001</td></tr><tr><td><italic>depK</italic></td><td>Cytochrome P450 monooxygenase, AneD</td><td>35/54</td><td>(A0A1L9WUS5.1): <italic>Aspergillus aculeatus</italic> ATCC 16872</td></tr><tr><td><italic>depL</italic></td><td>Putative protein</td><td>88/94</td><td>(XP_662543.1): <italic>Aspergillus nidulans</italic> FGSC A4</td></tr><tr><td><italic>depM</italic></td><td>3-Oxoacyl-reductase, FabG</td><td>35/52</td><td>(Q9X248.1): <italic>Thermotoga maritima</italic> MSB8</td></tr><tr><td><italic>1</italic></td><td>Putative protein</td><td>91/93</td><td>(XP_026605893.1): <italic>Aspergillus mulundensis</italic></td></tr><tr><td><italic>2</italic></td><td>Putative protein</td><td>89/95</td><td>(XP_662535.1): <italic>Aspergillus nidulans</italic> FGSC A4</td></tr></tbody></table><table-wrap-foot><fn id="tbl1fna"><label>a</label><p id="ntpara0015">ID/SI: Identity/Similarity.</p></fn></table-wrap-foot></table-wrap><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Biosynthetic gene cluster of DEPs, HPLC profiles, and proposed biosynthetic pathway of DEPs. (A) Gene cluster of DEPs; (B) HPLC profiles of the wide type strain and mutants of SCSIO SX7S7; (C) HPLC profiles of the PKS heterologous expression in <italic>A. nidulans</italic> A1145; (D) The proposed late-stage biosynthetic pathway of depsidones <bold>3</bold> and <bold>10</bold> based on biochemical and genetic evidence.</p></caption><alt-text id="alttext0025">Figure&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig></p><p id="p0030">To obtain the precursor derived from the <italic>dep</italic> cluster, we performed heterologous expression and constructed two plasmids that contain <italic>depD</italic> and <italic>depH</italic> for the protoplast transformation to the model fungus <italic>A. nidulans</italic> A1145<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref>. As a result, precursor <bold>1</bold>/<bold>2</bold> could be afforded only when the two PKS genes were expressed together (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>C). Meanwhile, the trace amounts of <bold>23</bold> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>) could also be detected by LC&#x02012;MS analyses either in the <italic>depD</italic> and <italic>depH</italic> coexpressing strain or <italic>depH</italic> expressing alone strain, but not in <italic>depD</italic> expressing alone strain (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S6</xref>). Thus, we deduced that DepH could catalyze the formation of <bold>23</bold> only, and the formation of <bold>1</bold>/<bold>2</bold> requires both two PKSs involved. Phylogenetic analysis of the SAT and TE domains of DepH showed that they are clustered with Preu6, an nrPKS is capable of catalyzing the formation of <bold>23</bold> (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S22</xref>) suggesting that the formation of depsides <bold>2</bold> and <bold>23</bold> is likely consistent with that of Preu6 (<xref rid="sch1" ref-type="fig">Scheme 1</xref>, Routes B, D)<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref>. Interestingly, the formation of unguidepside A (<bold>2</bold>) requires a hrPKS DepD, in which the ER domain may be malfunctional based on the observed &#x0201c;DSLG&#x0201d; NADPH binding site instead of the canonical &#x0201c;GGXG&#x0201d; site through the alignment of DepD ER domain with that in other fungal hrPKSs (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S23</xref>). Thus, DepD could generate 1-methyl-1-propenyl unit for nrPKS DepH (<xref rid="sch1" ref-type="fig">Scheme 1</xref>, Route D), which differs from previous reports that the formation of depside requires one nrPKS only (<xref rid="sch1" ref-type="fig">Scheme 1</xref>, Routes A&#x02012;C).</p></sec><sec id="sec2.2"><label>2.2</label><title>In&#x000a0;vivo <italic>and</italic> in&#x000a0;vitro <italic>experiments reveal the cytochrome P450 monooxygenase DepG catalyzes the installation of ether bond</italic></title><p id="p0035">To extend our understanding of DEPs biosynthesis, we next analyzed the genes neighboring <italic>depD</italic> and <italic>depH</italic> within the <italic>dep</italic> cluster. We envisioned that some of these genes might be responsible for catalyzing key tailoring steps <italic>en route</italic> to the depsidones. We first inactivated three putative oxidase genes (<italic>depG</italic>, <italic>depJ</italic>, and <italic>depK</italic>) in the <italic>dep</italic> cluster, which is thought to possibly catalyze the installation of ether bonds in the depsidones. Compared with the wild-type (WT) producer, HPLC-DAD finger spectra and (+)-LC&#x02012;HR-ESI-MS analyses of the three inactivated mutants, revealed that the &#x00394;<italic>depG</italic> mutant produced five new peaks (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>B, iv, <bold>17</bold>&#x02013;<bold>21</bold>), whereas the &#x00394;<italic>depJ</italic> and &#x00394;<italic>depK</italic> mutants produced an SM profile consistent with the WT producer (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S21</xref>). (+)-LC&#x02012;HRESIMS analysis of the &#x00394;<italic>depG</italic> mutant product profile showed that the molecular weights of the main products were 2&#x000a0;Da greater than their WT counterparts, suggesting that cytochrome P450 monooxygenase DepG likely drives the installation of the 6-<italic>O</italic>-5&#x02032; biaryl ether linkage in the depsidones. Furthermore, large-scale fermentation, isolation, and identification of the &#x00394;<italic>depG</italic> products revealed that this mutant no longer produced the 6/8/6 skeleton of the DEPs, but rather generated new depsides <bold>17</bold>&#x02013;<bold>21</bold> devoid of the biaryl ether linkage (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). The structures of <bold>17</bold>&#x02013;<bold>21</bold> were carefully elucidated by extensive HRESIMS, and 1D and 2D NMR data analysis (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S1</xref>, <xref rid="appsec1" ref-type="sec">Tables S7&#x02012;S8</xref>).</p><p id="p0040">In support of these findings, we also performed feeding experiments using the <italic>A. nidulans</italic> A1145-<italic>depG</italic> (AN-<italic>depG</italic>) strain. When compounds <bold>2</bold> and <bold>21</bold> were fed to AN-<italic>depG</italic>, depsidones <bold>5</bold> and <bold>21a</bold> could be readily observed. These data confirmed that DepG carries out biaryl ether bond installation in the DEPs (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>A). Since DepG is membrane-bound, <italic>in&#x000a0;vitro</italic> characterization of such an enzyme remains challenging (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S5</xref>). Herein, we prepared a high concentration of microsomal fraction of the strain AN-<italic>depG</italic>. Following the incubation of 0.1&#x000a0;mmol/L <bold>2</bold> with 420&#x000a0;&#x003bc;L microsomal DepG source, 2&#x000a0;mmol/L NADPH, and 100&#x000a0;mmol/L NaCl for 12&#x000a0;h, a putative bio-transformation product could be detected in HPLC-DAD analyses (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>B). The identity of the putative DepG product corresponded strongly to the compound <bold>5</bold> standard further validating that stand-alone DepG is able to catalyze the formation of ether bonds in the DEPs. In addition, precursors-direct biosynthesis might be possible to generate depsidone congeners for the development of anti-infectious agents with high activity.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p><italic>In&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> analysis of the cytochrome P450 monooxygenase DepG. (A) <italic>In&#x000a0;vivo</italic> biotransformation of DEP precursors in <italic>A. nidulans</italic> A1145/<italic>depG</italic> using <bold>2</bold> and <bold>21</bold> as the substrates; (B) HPLC traces of the DepG-catalyzed reactions using <bold>2</bold> as the substrate; (C) The verified substrates and reactions catalyzed by DepG.</p></caption><alt-text id="alttext0030">Figure&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p></sec><sec id="sec2.3"><label>2.3</label><title><italic>In&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> characterization of DepF as an efficient decarboxylase with promiscuous activity</title><p id="p0045">Previous SARs showed that decarboxylation of depsidones enhances their anti-pathogenic activity<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref>. Bioinformatic analysis of <italic>depF</italic> showed that it likely encodes for an amidohydrolase superfamily protein. This family has previously been shown to catalyze decarboxylation in diphenyl ethers<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref>. Thus, we envisioned that DepF might be responsible for the C-1&#x02032; decarboxylation in DEPs<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib21" ref-type="bibr">21</xref>. Notably, most members of this family require divalent metals for catalytic function. HPLC-DAD analyses showed that the main products of the &#x00394;<italic>depF</italic> mutant were compounds <bold>5</bold> and <bold>13</bold> containing the C-1&#x02032; carboxy moiety (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>B, iii). Combined (+)-LC&#x02012;HRESIMS analyses (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S2</xref>) with the &#x00394;<italic>depF</italic> product profile confirmed that DepF catalyzes decarboxylation during DEP assembly. To validate the function of DepF, intron-free <italic>depF</italic> was cloned, then overexpressed and purified from <italic>Escherichia coli</italic> BL21 (DE3) (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S4</xref>). As we expected, after an incubation of 20&#x000a0;&#x003bc;mol/L DepF with 100&#x000a0;&#x003bc;mol/L <bold>2</bold> and <bold>5</bold> for 2&#x000a0;h, the expectant conversions of <bold>2</bold> to <bold>2a</bold> and <bold>5</bold> to <bold>22</bold> could be readily detected (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>A). (+)-LC&#x02012;HRESIMS revealed the presence of both <bold>2a</bold> and <bold>22</bold> as decarboxylated products (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S7</xref>), providing clear evidence for the decarboxylation of DEPs by DepF. Interestingly, DepF incubations containing <bold>2</bold> or <bold>5</bold>, along with 10&#x000a0;mmol/L EDTA, were found to yield the products <bold>2a</bold> and <bold>22</bold>, respectively, suggesting that DepF might not require metal ions to decarboxylate DEP substrates. Using the optimal reaction conditions, we determined the kinetic constants for DepF. The <italic>K</italic><sub>m</sub> and <italic>k</italic><sub>cat</sub> values for DepF conversion of <bold>5</bold> to <bold>22</bold> were found to be 23.5&#x000a0;&#x003bc;mol/L and 4298.5/min respectively, and 10.3&#x000a0;&#x003bc;mol/L and 184.8/min for the conversion of <bold>2</bold> to <bold>2a</bold> (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>B). Thus, the optimum natural substrate for DepF was found to be depsidone <bold>5</bold>, and DepF was also found to have excellent catalytic activity.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Biochemical characterization of DepF. (A) <italic>In&#x000a0;vitro</italic> analyses of DepF using <bold>2</bold>, <bold>5</bold>, <bold>15</bold>, and <bold>24</bold> as substrates; (B) Kinetic constants for DepF-catalyzed reactions, using <bold>2</bold> and <bold>5</bold> as substrates; The inset numbers represent the determined kinetic constant values. Error bars are exhibited as SEM; (C) The verified substrates and reactions catalyzed by DepF. The asterisk mark indicates the decarboxylation position.</p></caption><alt-text id="alttext0035">Figure&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig></p><p id="p0050">Enzyme promiscuity plays an important role in developing diversified products<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib23" ref-type="bibr"><sup>23</sup></xref>. Owing to the efficient catalytic activity of DepF, the substrate range of this enzyme was also performed. When compound <bold>15</bold> was used as a substrate, the expected products of compound <bold>16</bold> could be detected by the trace of HPLC (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>A). Additionally, K1115A (<bold>24</bold>) obtained from one strain of <italic>Streptomyces</italic> sp. by our team was also used to test the substrate scope of DepF. Coincubation of <bold>24</bold> with DepF led to the formation of the expected product, 1,6-dihydroxy-8-propylanthraquinone (<bold>24a</bold>) (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>A), which was further confirmed by LC&#x02012;MS (<xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S7</xref>), indicating that DepF could also catalyze the decarboxylation of anthraquinones (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>C). Taken together, above results revealed that DepF might catalyze the decarboxylation during DEPs biosynthesis with a remarkable substrate scope, including on-pathway intermediates and other sources of compounds.</p></sec><sec id="sec2.4"><label>2.4</label><title>A3428 is a remotely encoded flavin-dependent halogenase capable of catalyzing multiple-halogenation within DEPs biosynthesis</title><p id="p0055">The discovery of many highly halogenated DEPs indicates the existence of a halogenase that might be responsible for multiple halogenations. To date, biochemical characterization of flavin-dependent halogenase which could catalyze the formation of multi-halogenated natural products in fungi is rare. It is of great significance to characterization of such an enzyme which might convert DEPs to highly halogenated DEPs.</p><p id="p0060">Bioinformatics analyses were carried out to identify candidate halogenase genes within the <italic>dep</italic> cluster. Interestingly, no such genes were found based on gene function annotations and gene disruption results (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S21</xref>). Therefore, we speculated that the gene encoding halogenase is located outside of the <italic>dep</italic> cluster. To identify the target halogenase involved in DEPs biosynthesis, we searched the reports on ortho halogenation of phenolic hydroxy group and found two flavin-dependent halogenases, RadH and AclH, responsible for radicicol and aspirochlorine halogenation, respectively<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="bib25" ref-type="bibr"><sup>25</sup></xref>. Upon comparison of RadH and AclH with all of the SX7S7 encoded putative proteins, a candidate A3428 that was 47% identical to RadH and 52% identical to AclH was found (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S12</xref>). However, other proteins were less than 35% identical. Notably, <italic>A3428</italic> does not appear to be a component of any previously identified SM gene clusters within SCSIO SX7S7. To validate A3428 as the halogenase responsible for DEPs biosynthesis, we inactivated <italic>A3428</italic> with CRISPR-Cas9 system. As expected, the mutant mainly accumulated compounds <bold>12</bold> and <bold>22</bold> as determined by HPLC-DAD analysis (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>B, vi). At the same time, compounds <bold>5</bold> and <bold>13</bold> could also be detected in (&#x02012;)-LC&#x02012;HRESIMS analyses, instead of the typical halogenated DEPs (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S3</xref>). Taken together, these results confidently demonstrated that flavin-dependent halogenase A3428, a remotely encoded biosynthetic tailoring enzyme, is essential for the halogenation of DEPs.</p><p id="p0065">To obtain direct <italic>in&#x000a0;vitro</italic> evidence for the biochemical functions of A3428, an approach similar to that taken for DepF was pursued. The intron-free <italic>A3428</italic> was cloned from the cDNA and heterologously overexpressed in <italic>E. coli</italic> BL21 (DE3) (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S4</xref>). The resulting enzyme was sufficiently pure for <italic>in&#x000a0;vitro</italic> enzyme assays with various substrates. Incubations of <bold>2</bold> with 15&#x000a0;&#x003bc;mol/L A3428, 2.5&#x000a0;mmol/L NADH, and 25&#x000a0;mmol/L MgCl<sub>2</sub> for 12&#x000a0;h afforded none of the putative products as determined by HPLC. However, upon the addition of 20&#x000a0;&#x003bc;mol/L of Fre (<italic>E. coli</italic> flavin reductase<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref>), monochlorinated <bold>17</bold> and dechlorinated <bold>2b</bold> were detected in the 4 and 8&#x000a0;h reactions, respectively (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>A, i&#x02012;iii). The identities of putative <bold>17</bold> and <bold>2b</bold> were further confirmed by (&#x02012;)-LC&#x02012;HRESIMS analyses (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S8</xref>). Thus, we demonstrated that the activity of A3428 is dependent upon the presence of a reductase partner. Further investigations revealed that A3428 could accept a range of substrates. With the exception of <bold>2</bold>, compounds <bold>12</bold> and <bold>22</bold> could be processed by A3428, and their polychlorinated products could be easily detected by HPLC (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>A, iv&#x02012;x) and LC&#x02012;MS (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S9</xref>). On the other hand, when MgCl<sub>2</sub> was replaced by KBr and KI, we found that putative A3428 products could only be detected in the KBr system. KI-containing reactions failed to yield any discernible halogenated derivates (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S10</xref>). Brominated DEPs were further confirmed by LC&#x02012;MS analysis (Supporting Information <xref rid="appsec1" ref-type="sec">Fig.&#x000a0;S11</xref>). These data indicated that A3428 could employ either MgCl<sub>2</sub> or KBr to afford assorted DEPs differing in their halogenation patterns. Collectively, we confirmed that A3428 as a flavin-dependent halogenase could finalize the installation of different halogen atoms during DEPs biosynthesis with broad substrate scope and represent an important advance that will likely enable enhanced access to new DEPs as potential new compounds or drug leads.<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p><italic>In&#x000a0;vitro</italic> analysis of the flavin-dependent halogenase A3428. (A) HPLC traces of the A3428-catalyzed reactions; (B) The verified substrates and reactions catalyzed by A3428.</p></caption><alt-text id="alttext0040">Figure&#x000a0;5</alt-text><graphic xlink:href="gr5"/></fig></p></sec><sec id="sec2.5"><label>2.5</label><title>Antibacterial activity assays</title><p id="p0070">Finally, we investigated the antimicrobial activities of the new depsides <bold>17</bold>&#x02013;<bold>21</bold> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). Compounds <bold>18</bold> and <bold>20</bold> were both found to possess antibacterial activities against a series of Gram-positive pathogens with minimum inhibitory concentrations (MICs) span-ning from 2 to 16&#x000a0;&#x003bc;g/mL (Supporting Information <xref rid="appsec1" ref-type="sec">Table S2</xref>). Conversely, compounds <bold>17</bold>, <bold>19</bold>, and <bold>21</bold> displayed only weak anti-pathogenic activities with MIC values&#x000a0;&#x02265;&#x000a0;32&#x000a0;&#x003bc;g/mL (<xref rid="appsec1" ref-type="sec">Table S2</xref>). These results suggest that decarboxylated DEPs appear to have slightly superior antimicrobial activities relative to those bearing the C-1&#x02032; acid moiety. These findings support previously established SAR datasets<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref>.</p></sec></sec><sec id="sec3"><label>3</label><title>Conclusions</title><p id="p0075">Overall, the BGC encoding the DEPs was identified and characterized from our previously reported fungus <italic>Aspergillus</italic> sp. SCSIO SX7S7. Based on the CRISPR-Cas9 gene disruption system and heterologous expression experiments, we discovered that both hrPKS DepD and nrPKS DepH are indispensable to forming the precursor unguidepside A (<bold>2</bold>), which is distinct from previous depside formation. In addition, a CRISPR-Cas9-based gene disruption system and <italic>in&#x000a0;vitro</italic> enzyme assays played essential roles in our elucidation of key tailoring steps involved in nornidulin (<bold>3</bold>) biosynthesis (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>D). The functions of three key tailoring enzymes were determined. The cytochrome P450 monooxygenase DepG converts the bicyclic depsides to tricyclic depsidones. The amidohydrolase superfamily protein DepF decarboxylates depsidone substrates, and finally, an uncommon flavin-dependent and remotely encoded halogenase A3428 catalyzes the multiple halogenations of depsides and depsidones. Coordinated with these efforts, we have also identified five new depside intermediates from an engineered &#x00394;<italic>depG</italic> mutant, which exhibited moderate anti-pathogenic activities, indicating the potential of these molecules act as promising anti-infective drug lead compounds. Collectively, the discovery of the late-stage tailoring enzymes including DepF, DepG, and A3428, exhibit broad substrate promiscuity, which suggests their potential as genetic tools to expand DEP structural diversity. This study expands the foundation for future biosynthetic studies and bioengineering efforts to vastly enrich depsidone and depside structure libraries for initiatives in drug discovery and SM enzymology.</p></sec><sec id="sec4"><label>4</label><title>Experimental</title><sec id="sec4.1"><label>4.1</label><title>General experimental procedures</title><p id="p0080">U-2910 spectrometer (Hitachi) was used to record the UV spectra of compounds <bold>17</bold>&#x02013;<bold>21</bold>. The 1D and 2D NMR spectra of compounds <bold>17</bold>&#x02013;<bold>21</bold> were obtained with a Bruker Avance-700 spectrometer. All of the mass spectra were acquired on a Bruker MaXis Q-TOF mass spectrometer. Semi-preparative HPLC was performed on an Agilent 1260 HPLC system with a C<sub>18</sub> column (YMC, 10&#x000a0;mm&#x000a0;&#x000d7;&#x000a0;250&#x000a0;mm, 5&#x000a0;&#x003bc;m).</p><p id="p0085">Strains and constructed plasmids utilized are shown in Supporting Information <xref rid="appsec1" ref-type="sec">Tables S3&#x02012;S4</xref>. LB medium was added with an additional antibiotic at a concentration of 50&#x000a0;&#x003bc;g/mL carbenicillin or 50&#x000a0;&#x003bc;g/mL kanamycin when necessary. Solid CD Medium was used for incubations of <italic>A. nidulans</italic> A1145 and <italic>Aspergillus</italic> sp. SCSIO SX7S7. The mutant strains of SCSIO SX7S7 were grown at Solid CD Medium with additional 200&#x000a0;&#x003bc;g/mL hygromycin (Hyg). Analytical or chromatographic-grade chemicals and solvents were used in this study.</p></sec><sec id="sec4.2"><label>4.2</label><title>DNA/RNA isolation, sequencing and manipulation</title><p id="p0090">Genomic DNA from all fungal strains was prepared using lysis buffer (Supporting Information <xref rid="appsec1" ref-type="sec">Table S6</xref>). Whole genome scanning of <italic>Aspergillus</italic> sp. SCSIO SX7S7 was finished using the 2nd generation Illumina sequencing platforms and 3rd generation PacBio RS (Shanghai Biozeron Biotechnology). The engineered yeast <italic>Saccharomyces cerevisiae</italic> JHY686-YH<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> was used to construct all of the <italic>A. nidulans</italic> A1154 &#x00394;EM expression recombination plasmids.</p><p id="p0095"><italic>Aspergillus</italic> sp. SCSIO SX7S7 was statically grown on PDB medium at 28&#x000a0;&#x000b0;C for 5 days and the mycelia were then collected. The total RNA was extracted from the mycelia following the manufacturer of the Coolaber&#x000ae; Fungal RNA Extraction Kit (Coolaber Technology, China) protocol. One-Step gDNA Removal and cDNA Synthesis SuperMix Kit (TransGen, China) was used to prepare the cDNA of SCSIO SX7S7.</p></sec><sec id="sec4.3"><label>4.3</label><title>Bioinformatic analysis</title><p id="p0100">SM BGCs were analyzed using antiSMASH 6.0.0alpha software<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref>. <italic>Orfs</italic> were assigned and their functions were predicted using FramePlot 4.0beta software, 2ndfiner software, and the BLAST program. MEGA 7.0 and ClustalX software were used to align the sequences.</p></sec><sec id="sec4.4"><label>4.4</label><title>HPLC analysis</title><p id="p0105">The metabolites of <italic>Aspergillus</italic> sp. SCSIO SX7S7 and their mutants and <italic>A. nidulans</italic> A1145 were analyzed using an Agilent ZORBAX SB-C18 column (150&#x000a0;mm&#x000a0;&#x000d7;&#x000a0;4.6&#x000a0;mm, 5&#x000a0;&#x003bc;m) with DAD detector under the solvent system (phase A, ddH<sub>2</sub>O with 1&#x02030; TFA; phase B, CH<sub>3</sub>CN with 1&#x02030; TFA): 0&#x02212;20&#x000a0;min 5%&#x02013;80% phase B; 20&#x02212;23&#x000a0;min 80%&#x02013;100% phase B; 23&#x02212;27&#x000a0;min 100% phase B; 27&#x02212;27.5&#x000a0;min 100%&#x02013;0% phase B; 27.5&#x02212;30&#x000a0;min 5% phase B; flow rate of 1&#x000a0;mL/min.</p></sec><sec id="sec4.5"><label>4.5</label><title>Preparation of protoplast A. nidulans A1154 and Aspergillus sp. SCSIO SX7S7 organisms</title><p id="p0110">The general fungal transformation method has been previously described in detail elsewhere<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref>. Briefly, for the transformation of A1145 and SCSIO SX7S7, spores were first grown on 50&#x000a0;mL liquid CD media which contains uridine (10&#x000a0;mmol/L), uracil (5&#x000a0;mmol/L), pyridoxine (0.5&#x000a0;&#x003bc;g/mL) and riboflavin (2.5&#x000a0;&#x003bc;g/mL) in a 250&#x000a0;mL flask at 28&#x000a0;&#x000b0;C, 200&#x000a0;rpm for about 12&#x000a0;h. Then, the germinated spores which were confirmed by microscopic examination were harvested and washed with 20&#x000a0;mL osmotic buffer (Supporting Information <xref rid="appsec1" ref-type="sec">Table S6</xref>). Lysing enzyme (4&#x000a0;mg/mL, Sigma&#x02013;Aldrich, Germany) and Yatalase (3&#x000a0;mg/mL, Takara, Japan) were used to prepare the protoplasts. Protoplasts were prepared by incubating the mixture in 10&#x000a0;mL osmotic buffer at 28&#x000a0;&#x000b0;C, 80&#x000a0;rpm for 10&#x000a0;h. The mixture was collected and transformed into a 30&#x000a0;mL sterile glass tube and overlaid carefully with 12&#x000a0;mL Trapping buffer (Supporting Information <xref rid="appsec1" ref-type="sec">Table S6</xref>). After centrifugation (3900&#x000a0;rpm, 30&#x000a0;min, 4&#x000a0;&#x000b0;C), the protoplasts at the interface were carefully transformed into a 15&#x000a0;mL sterile tube and washed with 15&#x000a0;mL 1&#x000a0;&#x000d7;&#x000a0;STC buffer (<xref rid="appsec1" ref-type="sec">Table S6</xref>).</p></sec><sec id="sec4.6"><label>4.6</label><title>Construction of heterogenous expression strain</title><p id="p0115">The heterologous expression plasmids were constructed using the plasmids pYTU (uracil used as an auxotrophic marker) and pYTP (pyridoxine used as an auxotrophic marker) as vectors to insert target genes<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref>.</p><p id="p0120">For example, to construct the pYTU-depG plasmid, gene <italic>depG</italic> was amplified by PCR with a pair of primers of Recomb-pYTU-depG F1/R1 (Supporting Information <xref rid="appsec1" ref-type="sec">Table S5</xref>). Then, the overlapping DNA fragment and the vector (digested by PacI and SwaI) were transformed into <italic>S. cerevisiae</italic> JHY686-YH for homologous recombination. Zymoprep&#x02122; Yeast Plasmid Miniprep Kit (Zymo Research, USA) was used to extract the plasmids in <italic>S. cerevisiae</italic> JHY686-YH and then introduced into <italic>E. coli</italic> DH5<italic>&#x003b1;</italic> by transformation. Recombined plasmids were sequenced to confirm identities. The remaining <italic>A. nidulans</italic> plasmids were generated following the same protocol of pYTU-depG. The resulting recombinant plasmids are listed in <xref rid="appsec1" ref-type="sec">Table S2</xref>. For <italic>A. nidulans</italic> transformation, 1&#x000a0;&#x003bc;g pYTU-depG, 1&#x000a0;&#x003bc;g pYTP, and 1&#x000a0;&#x003bc;g pYTR were added to 70&#x000a0;&#x003bc;L protoplast and incubated on ice for 1&#x000a0;h. Next, 500&#x000a0;&#x003bc;L of PEG solution (<xref rid="appsec1" ref-type="sec">Table S6</xref>) was added to the mixture for another 30&#x000a0;min and spread onto the CD-Sorbitol Medium (<xref rid="appsec1" ref-type="sec">Table S6</xref>) and incubated at 28&#x000a0;&#x000b0;C until the transformants could be picked onto the CD-ST media (<xref rid="appsec1" ref-type="sec">Table S6</xref>) for the production of heterologously expressed metabolites.</p></sec><sec id="sec4.7"><label>4.7</label><title>Construction of CRISPR-Cas9 plasmids for fungal transformation</title><p id="p0125">The construction of our CRISPR-Cas9 plasmids has been previously described<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref>. For further construction of plasmids used in the Cas9-based gene disruption system. Two overlapped fragments for overexpression of the single guide RNA (sgRNA) containing the target gene-specific protospacer sequence and the sgRNA scaffold sequence were amplified by PCR with two sets of primers of Cas9-sgDNA F/R and Cas9-depG F1/R1 (Supporting Information <xref rid="appsec1" ref-type="sec">Table S5</xref>) using pFC332 as the template<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref>. The fragments were inserted into the BsaI-digested pBSKII-Cas9-hph vector by Seamless Cloning and Assembly Kit (TransGen, China) and were introduced into commercial <italic>E. coli</italic> DH5<italic>&#x003b1;</italic> by transformation. Plasmids were then sequenced to confirm identities and named pCas9-depG. The remaining CRISPR-Cas9 gene disruption plasmids were generated following the same protocol of pCas9-depG. The gene-specific protospacer sequence was designed using an online website (<ext-link ext-link-type="uri" xlink:href="http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx" id="intref0010">http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx</ext-link>).</p></sec><sec id="sec4.8"><label>4.8</label><title>Gene disruption with CRISPR-Cas9 system</title><p id="p0130">The transformation of strain SCSIO SX7S7 was similar to the <italic>A. nidulans</italic> A1145 transformation described above. Briefly, 2.5&#x000a0;&#x003bc;g constructed CRISPR-Cas9 gene disruption plasmids listed in <xref rid="appsec1" ref-type="sec">Table S3</xref> were added to 75&#x000a0;&#x003bc;L <italic>Aspergillus</italic> sp. SCSIO SX7S7 protoplast suspension. Then 25&#x000a0;&#x003bc;L of PEG solution was added after blending and incubation on ice for 1&#x000a0;h. Subsequently, one milliliter of PEG solution was added for another 30&#x000a0;min at 28&#x000a0;&#x000b0;C and the mixture was spread onto CD Solid medium (<xref rid="appsec1" ref-type="sec">Table S6</xref>) supplemented with 200&#x000a0;&#x003bc;g/mL hygromycin. Cultured onto CD agar medium (<xref rid="appsec1" ref-type="sec">Table S6</xref>) supplemented with 200&#x000a0;&#x003bc;g/mL hygromycin at 28&#x000a0;&#x000b0;C until the transformants could be picked. Individual clones were validated by PCR amplified with proper primers flanking the target site.</p></sec><sec id="sec4.9"><label>4.9</label><title>Preparation of microsomal fraction from the A1145-depG</title><p id="p0135">The A1145-depG strain harboring pYTU-depG was cultured in 30&#x000a0;mL CD-ST medium (28&#x000a0;&#x000b0;C, 200&#x000a0;rpm, 3 days). Then the mycelia were harvested and resuspended in A Buffer (<xref rid="appsec1" ref-type="sec">Table S6</xref>). 100&#x000a0;&#x003bc;L zirconium silicate beads were added and broken in a bullet blender (Next Advance, USA) at 4&#x000a0;&#x000b0;C for 5&#x000a0;min. The homogenate was then centrifuged (14,000&#x000a0;rpm, 4&#x000a0;&#x000b0;C, 10&#x000a0;min) to remove the deposit. The supernatant was further fractionated by centrifugation at 14,000&#x000a0;rpm and 4&#x000a0;&#x000b0;C for 8&#x000a0;h. The microsome extracts were then resuspended in a total of 500&#x000a0;&#x003bc;L&#x000a0;B Buffer (<xref rid="appsec1" ref-type="sec">Table S6</xref>) and stored at &#x02212;80&#x000a0;&#x000b0;C.</p></sec><sec id="sec4.10"><label>4.10</label><title>Cloning, expression, and purification of A3428, DepF and Fre</title><p id="p0140">The gene for A3428/DepF from WT SCSIO SX7S7 cDNA was amplified by PCR with a pair of primers of pET28a-A3428/DepF-F1/R1 (<xref rid="appsec1" ref-type="sec">Table S5</xref>) and cloned into the pET28a(+) overexpression vector (digested with NdeI and EcoRI). The sequence confirmed reconstruction plasmid of pET28a-A3428/DepF was used to transform to <italic>E. coli</italic> BL21(DE3) (TransGen, China) for overexpression of the A3428/DepF. The strain harboring pET28a-A3428/DepF was further cultured in 50&#x000a0;mL LB medium overnight and grown at 37&#x000a0;&#x000b0;C. Subsequently, two milliliters of BL21/pET28a-A3428/DepF culture was transferred into 500&#x000a0;mL LB medium for further incubation at 28&#x000a0;&#x000b0;C until the absorbance at 600&#x000a0;nm reached 0.3. Isopropylthio-<italic>&#x003b2;</italic>-<sc>d</sc>-galactoside (IPTG, 0.5&#x000a0;mmol/L) was used to induce the protein overexpression and the IPTG added culture was further incubated at 16&#x000a0;&#x000b0;C (160&#x000a0;rpm, 18&#x000a0;h). A total of 10&#x000a0;mL cells were harvested and resuspend in 25&#x000a0;mL lysis buffer (<xref rid="appsec1" ref-type="sec">Table S6</xref>). The overexpressed A3428 and DepF were further purified using Qiagen Ni<sup>2+</sup>-NTA affinity resin and eluted with buffer containing Tris-HCl (50&#x000a0;mmol/L), NaCl (300&#x000a0;mmol/L) and imidazole (300&#x000a0;mmol/L), pH 8.0. The crude extract containing A3428 or DepF was further purified by size-exclusion chromatography on a Superdex 200 column equilibrated in the storage buffer (<xref rid="appsec1" ref-type="sec">Table S6</xref>). The flavin reductase enzyme (Fre) from <italic>E. coli</italic> BL21 (DE3) was also purified like protein A3428/DepF.</p></sec><sec id="sec4.11"><label>4.11</label><title>Feeding experiments and in&#x000a0;vitro enzymatic reaction</title><p id="p0145">The transformant strain <italic>A. nidulans</italic> A1145/depG was cultured on CD agar medium for 3 days as seed. The A1145/depG mycelia were then inoculated into 30&#x000a0;mL CD-ST medium with 1&#x000a0;mmol/L substrate dissolved in 100&#x000a0;&#x003bc;L DMSO after growing for 2 days. Subsequently, the transformant strain was cultured for an additional 24&#x000a0;h. The culture broth was collected and extracted with butanone for HPLC analysis.</p><p id="p0150">A total of 500&#x000a0;&#x003bc;L reaction mixture, containing 427.5&#x000a0;&#x003bc;L microsomal fraction of the <italic>A. nidulans</italic> A1145/depG strain, 2&#x000a0;mmol/L NADPH, 100&#x000a0;mmol/L NaCl, and 0.1&#x000a0;mmol/L substrate was incubated at 30&#x000a0;&#x000b0;C for 24&#x000a0;h. Subsequently, the reaction mixture was extracted twice with EtOAc. After removal of solvent <italic>in vacuo</italic>, the extracted fraction was finally dissolved in methanol for HPLC and LC&#x02012;HRESIMS analysis.</p><p id="p0155">Purified DepF (20&#x000a0;&#x003bc;mol/L) was incubated with substrate (0.1&#x000a0;mmol/L) to a total volume of 100&#x000a0;&#x003bc;L&#x000a0;at 30&#x000a0;&#x000b0;C with shaking at 300&#x000a0;rpm for 2&#x000a0;h in PBS buffer (10&#x000a0;mmol/L, pH 7.4). Purified A3428 (20&#x000a0;&#x003bc;mol/L) was incubated with Fre (10&#x000a0;&#x003bc;mol/L), FAD (10&#x000a0;&#x003bc;mol/L), NADH (2.5&#x000a0;mmol/L), MgCl<sub>2</sub> (25&#x000a0;mmol/L), DTT (0.1&#x000a0;mmol/L) and substrate (0.1&#x000a0;mmol/L) to a total volume of 100&#x000a0;&#x003bc;L&#x000a0;at 30&#x000a0;&#x000b0;C for 4/12&#x000a0;h in PBS buffer (10&#x000a0;mmol/L, pH 7.4). Then added an equal amount of methanol and centrifugated to remove the precipitated protein. The supernate was directly used for HPLC and LC&#x02012;HRESIMS analysis.</p></sec><sec id="sec4.12"><label>4.12</label><title>Determination of kinetic constants</title><p id="p0160">To investigate the forward reaction kinetic constants of DepF, reaction mixtures were prepared in PBS buffer (10&#x000a0;mmol/L, pH 7.4) containing DepF (420&#x000a0;pmol/L for compound <bold>2</bold>, 4.5&#x000a0;nmol/L for compound <bold>5</bold>), and substrate (at 5, 10, 25, 50, 100, 200, 300, 400, and 500&#x000a0;&#x003bc;mol/L) in a total volume of 50&#x000a0;&#x003bc;L. Each reaction mixture was incubated at 30&#x000a0;&#x000b0;C for 8&#x000a0;min. The reaction was terminated by adding an equal amount of methanol. After centrifugation, the supernate was used for HPLC and LC&#x02012;HRESIMS analysis. Activity data were evaluated by integrating HPLC analysis. Kinetic constants were generated by fitting these data to the Michaelis&#x02013;Menten equation using Origin2017 software. Error bars were exhibited as SEM and calculated from three measurements.</p></sec><sec id="sec4.13"><label>4.13</label><title>Fermentation and isolation</title><p id="p0165">The &#x00394;<italic>depG</italic> mutant was placed onto CD agar medium containing 200&#x000a0;&#x003bc;g/mL Hyg at 28&#x000a0;&#x000b0;C for 5&#x000a0;days. Transferred the mycelium to PDB medium and incubated as seed cultures for 24&#x000a0;h (28&#x000a0;&#x000b0;C, 200&#x000a0;rpm). Subsequently, five milliliters of the seed culture were then inoculated into a 1&#x000a0;L flask (containing 200&#x000a0;mL PDB), shaking at 200&#x000a0;rpm for 7 days at 28&#x000a0;&#x000b0;C. After harvesting, a total of 12&#x000a0;L fermentation culture was centrifuged, and the mycelium cake and supernatant were extracted with acetone and butanone, respectively. The crude material mixture was subjected to a silica gel CC using a gradient of chloroform/methanol system (1:0&#x000a0;&#x02192;&#x000a0;1:1, <italic>v</italic>/<italic>v</italic>) to afford a total of nine fractions (Frs. A1&#x02212;A9). Frs. A1&#x02012;A4 mixture was further purified by medium-pressure preparative liquid chromatography (ODS column, 40&#x02013;63&#x000a0;&#x003bc;m, YMC), eluting with CH<sub>3</sub>CN/H<sub>2</sub>O (1:9&#x000a0;&#x02192;&#x000a0;9:1, <italic>v</italic>/<italic>v</italic>) over 90&#x000a0;min at 15&#x000a0;mL/min, which afforded Frs. B1&#x02012;B9. Frs. B3&#x02012;B5 were further mixed and subjected to silica gel CC eluting with petroleum ether/chloroform gradient (1:0&#x000a0;&#x02192;&#x000a0;0:1, <italic>v</italic>/<italic>v</italic>) to get 10 fractions (Frs. C1&#x02212;C10). The compounds <bold>17</bold>&#x02013;<bold>21</bold> were observed in Fr.C3. Compounds <bold>17</bold>&#x02013;<bold>21</bold> were separated on YMC ODS-A semi-HPLC column with elution system (A: H<sub>2</sub>O; B: CH<sub>3</sub>CN): 0&#x02212;27&#x000a0;min, 53%&#x02013;85% phase B; 27&#x02212;30&#x000a0;min, 53% phase B. As a result, compound <bold>17</bold> (16.7&#x000a0;mg, <italic>t</italic><sub>R</sub>&#x000a0;=&#x000a0;15.2&#x000a0;min), compound <bold>18</bold> (8.7&#x000a0;mg, <italic>t</italic><sub>R</sub>&#x000a0;=&#x000a0;16.1&#x000a0;min), compound <bold>19</bold> (5.4&#x000a0;mg, <italic>t</italic><sub>R</sub>&#x000a0;=&#x000a0;18.0&#x000a0;min), compound <bold>20</bold> (19.4&#x000a0;mg, <italic>t</italic><sub>R</sub>&#x000a0;=&#x000a0;19.0&#x000a0;min) and compound <bold>21</bold> (12.3&#x000a0;mg, <italic>t</italic><sub>R</sub>&#x000a0;=&#x000a0;24.1&#x000a0;min) were purified.</p></sec><sec id="sec4.14"><label>4.14</label><title>Antipathogens activity assays</title><p id="p0170">The antibacterial activities of compounds <bold>17</bold>&#x02013;<bold>21</bold> were evaluated in this study using broth microdilution-based antimicrobial susceptibility tests for pathogens<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref>. The tested Gram-positive bacteria were listed in Supporting Information <xref rid="appsec1" ref-type="sec">Table S2</xref>.</p></sec><sec id="sec4.15"><label>4.15</label><title>Characterization of compounds</title><p id="p0175">5-Chlorounguidepside (<bold>17</bold>): White power; UV (MeOH) <italic>&#x003bb;</italic><sub>max</sub> (log <italic>&#x003b5;</italic>) 215 (5.19), 273 (4.87), 308 (4.54) nm; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref rid="appsec1" ref-type="sec">Tables S7 and S8</xref>; (&#x02012;)-HRESIMS <italic>m</italic>/<italic>z</italic> 405.0756 [M&#x02012;H]<sup>&#x02012;</sup> (calcd. for C<sub>20</sub>H<sub>18</sub>Cl<sub>2</sub>O<sub>7</sub>, 405.0741).</p><p id="p0180">5-Chlorodecarboxyunguidepside (<bold>18</bold>): White power; UV (MeOH) <italic>&#x003bb;</italic><sub>max</sub> (log <italic>&#x003b5;</italic>) 217 (5.74), 270 (5.36), 306 (4.93) nm; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref rid="appsec1" ref-type="sec">Tables S7 and S8</xref>; (&#x02012;)-HRESIMS <italic>m</italic>/<italic>z</italic> 361.0845 [M&#x02012;H]<sup>&#x02012;</sup> (calcd. for C<sub>19</sub>H<sub>18</sub>ClO<sub>5</sub>, 361.0843).</p><p id="p0185">3,5-Chlorounguidepside (<bold>19</bold>): White power; UV (MeOH) <italic>&#x003bb;</italic><sub>max</sub> (log <italic>&#x003b5;</italic>) 222 (5.50), 268 (5.08), 306 (4.93) nm; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref rid="appsec1" ref-type="sec">Tables S7 and S8</xref>; (&#x02012;)-HRESIMS <italic>m</italic>/<italic>z</italic> 439.0357 [M&#x02012;H]<sup>&#x02012;</sup> (calcd. for C<sub>20</sub>H<sub>17</sub>Cl<sub>2</sub>O<sub>7</sub>, 439.0351).</p><p id="p0190">3,5-Chlorodecarboxyunguidepside (<bold>20</bold>): White power; UV (MeOH) <italic>&#x003bb;</italic><sub>max</sub> (log <italic>&#x003b5;</italic>) 217 (5.78), 254 (5.37), 319 (5.27) nm; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref rid="appsec1" ref-type="sec">Tables S7 and S8</xref>; (&#x02012;)-HRESIMS <italic>m</italic>/<italic>z</italic> 395.0465 [M&#x02012;H]<sup>&#x02012;</sup> (calcd. for C<sub>19</sub>H<sub>17</sub>Cl<sub>2</sub>O<sub>5</sub>, 395.0453).</p><p id="p0195">3-Chloroagonodepside (<bold>21</bold>): White power; UV (MeOH) <italic>&#x003bb;</italic><sub>max</sub> (log <italic>&#x003b5;</italic>) 219 (5.90), 270 (5.42), 311 (5.17) nm; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref rid="appsec1" ref-type="sec">Tables S7 and S8</xref>; (&#x02012;)-HRESIMS <italic>m</italic>/<italic>z</italic> 459.1220 [M&#x02012;H]<sup>&#x02012;</sup> (calcd. for C<sub>24</sub>H<sub>24</sub>ClO<sub>7</sub>, 459.1211).</p></sec></sec><sec id="sec6"><title>Acknowledgments</title><p id="p0200a">This research was funded by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100014717</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> (22037006, U2106207, 22077128), <funding-source id="gs2">Local Innovation and Entrepreneurship Team Project of Guangdong</funding-source> (2019BT02Y262, China), <funding-source id="gs3">Key Science and Technology Project of Hainan Province</funding-source> (ZDKJ202018, China), <funding-source id="gs4">Major Project of Basic and Applied Basic Research of Guangdong Province</funding-source> (2019B030302004, China), <funding-source id="gs5">Key-Area Research and Development Program of Guangdong Province</funding-source> (2020B1111030005, China), Guangdong Provincial Marine Economic Development (Six Major Marine Undertakings, China) Special Fund Project (GDNRC[2021]54, China) and <funding-source id="gs6">Open Program of Shenzhen Bay Laboratory</funding-source> (SZBL2021080601006, China). We thank The Analytical Facility Center of the South China Sea Institute of Oceanology. In particular, we acknowledge Dr. Zhihui Xiao and Dr. Xiaohong Zheng for recording NMR data, Ms. Aijun Sun, Ms. Yun Zhang, and Ms. Xuan Ma for acquiring HRESIMS data.</p></sec><sec id="sec5"><title>Author contributions</title><p id="p0200">Jianhua Ju and Yongxiang Song designed research; Jiafan Yang and Zhenbin Zhou performed research; Jiafan Yang, Zhenbin Zhou, Yingying Chen, Yongxiang Song and Jianhua Ju analyzed data; Jiafan Yang, Yingying Chen and Jianhua Ju wrote the manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p id="p0205">The authors declare no conflicts of interest.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>S.R.M.</given-names></name><name><surname>Mohamed</surname><given-names>G.A.</given-names></name><name><surname>Al Haidari</surname><given-names>R.A.</given-names></name><name><surname>El-Kholy</surname><given-names>A.A.</given-names></name><name><surname>Zayed</surname><given-names>M.F.</given-names></name><name><surname>Khayat</surname><given-names>M.T.</given-names></name></person-group><article-title>Biologically active fungal depsidones: chemistry, biosynthesis, structural characterization, and bioactivities</article-title><source>Fitoterapia</source><volume>129</volume><year>2018</year><fpage>317</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">29704531</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Duong</surname><given-names>T.H.</given-names></name><name><surname>Hang</surname><given-names>T.X.</given-names></name><name><surname>Pogam</surname><given-names>P.L.</given-names></name><name><surname>Tran</surname><given-names>T.N.</given-names></name><name><surname>Mac</surname><given-names>D.H.</given-names></name><name><surname>Dinh</surname><given-names>M.H.</given-names></name><etal/></person-group><article-title><italic>&#x003b1;</italic>-Glucosidase inhibitory depsidones from the lichen <italic>Parmotrema tsavoense</italic></article-title><source>Planta Med</source><volume>86</volume><year>2020</year><fpage>776</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">32483775</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Sukandar</surname><given-names>E.R.</given-names></name><name><surname>Siripong</surname><given-names>P.</given-names></name><name><surname>Khumkratok</surname><given-names>S.</given-names></name><name><surname>Tip-Pyang</surname><given-names>S.</given-names></name></person-group><article-title>New depsidones and xanthone from the roots of <italic>Garcinia schomburgkiana</italic></article-title><source>Fitoterapia</source><volume>111</volume><year>2016</year><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">27102610</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Zwartsen</surname><given-names>A.</given-names></name><name><surname>Chottanapund</surname><given-names>S.</given-names></name><name><surname>Kittakoop</surname><given-names>P.</given-names></name><name><surname>Navasumrit</surname><given-names>P.</given-names></name><name><surname>Ruchirawat</surname><given-names>M.</given-names></name><name><surname>Van Duursen</surname><given-names>M.B.M.</given-names></name><etal/></person-group><article-title>Evaluation of anti-tumour properties of two depsidones&#x02012;Unguinol and Aspergillusidone D&#x02012;in triple-negative MDA-MB-231 breast tumour cells</article-title><source>Toxicol Rep</source><volume>6</volume><year>2019</year><fpage>1216</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">31788435</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Bay</surname><given-names>M.V.</given-names></name><name><surname>Nam</surname><given-names>P.C.</given-names></name><name><surname>Quang</surname><given-names>D.T.</given-names></name><name><surname>Mechler</surname><given-names>A.</given-names></name><name><surname>Hien</surname><given-names>N.K.</given-names></name><name><surname>Hoa</surname><given-names>N.T.</given-names></name><etal/></person-group><article-title>Theoretical study on the antioxidant activity of natural depsidones</article-title><source>ACS Omega</source><volume>5</volume><year>2020</year><fpage>7895</fpage><lpage>7902</lpage><pub-id pub-id-type="pmid">32309698</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Urena-Vacas</surname><given-names>I.</given-names></name><name><surname>Gonzalez-Burgos</surname><given-names>E.</given-names></name><name><surname>Divakar</surname><given-names>P.K.</given-names></name><name><surname>Gomez-Serranillos</surname><given-names>M.P.</given-names></name></person-group><article-title>Lichen depsidones with biological interest</article-title><source>Planta Med</source><volume>88</volume><year>2021</year><fpage>855</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">34034351</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Morshed</surname><given-names>M.T.</given-names></name><name><surname>Vuong</surname><given-names>D.</given-names></name><name><surname>Crombie</surname><given-names>A.</given-names></name><name><surname>Lacey</surname><given-names>A.E.</given-names></name><name><surname>Karuso</surname><given-names>P.</given-names></name><name><surname>Lacey</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Expanding antibiotic chemical space around the nidulin pharmacophore</article-title><source>Org Biomol Chem</source><volume>16</volume><year>2018</year><fpage>3038</fpage><lpage>3051</lpage><pub-id pub-id-type="pmid">29634062</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.F.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>Z.B.</given-names></name><name><surname>Song</surname><given-names>Y.X.</given-names></name><name><surname>Ju</surname><given-names>J.H.</given-names></name></person-group><article-title>Anti-pathogenic depsidones and its derivatives from a coral-derived fungus <italic>Aspergillus</italic> sp. SCSIO SX7S7</article-title><source>Biochem Systemat Ecol</source><volume>102</volume><year>2022</year><fpage>104415</fpage><lpage>104419</lpage></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Arquie</surname><given-names>E.</given-names></name><name><surname>Grumbach</surname><given-names>F.</given-names></name><name><surname>Boyer</surname><given-names>F.</given-names></name><name><surname>Sanchez</surname><given-names>G.</given-names></name></person-group><article-title>A new antibiotic produced by a strain of <italic>Sterygmatocystis nidulans</italic>, nidulin</article-title><source>C R Hebd Seances Acad Sci</source><volume>229</volume><year>1949</year><fpage>602</fpage><lpage>604</lpage></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Matsuda</surname><given-names>Y.</given-names></name></person-group><article-title>Depside bond formation by the starter-unit acyltransferase domain of a fungal polyketide synthase</article-title><source>J Am Chem Soc</source><volume>144</volume><year>2022</year><fpage>19225</fpage><lpage>19230</lpage><pub-id pub-id-type="pmid">36223511</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Z.P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name></person-group><article-title>Diaryl ether formation by a versatile thioesterase domain</article-title><source>J Am Chem Soc</source><volume>144</volume><year>2022</year><fpage>9554</fpage><lpage>9558</lpage><pub-id pub-id-type="pmid">35639490</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Didepside formation by the nonreducing polyketide synthase Preu6 of <italic>Preussia isomera</italic> requires interaction of starter acyl transferase and thioesterase domains</article-title><source>Angew Chem Int Ed Engl</source><year>2022</year><object-id pub-id-type="publisher-id">e202214379</object-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Isaka</surname><given-names>M.</given-names></name><name><surname>Yangchum</surname><given-names>A.</given-names></name><name><surname>Supothina</surname><given-names>S.</given-names></name><name><surname>Veeranondha</surname><given-names>S.</given-names></name><name><surname>Komwijit</surname><given-names>S.</given-names></name><name><surname>Phongpaichit</surname><given-names>S.</given-names></name></person-group><article-title>Semisynthesis and antibacterial activities of nidulin derivatives</article-title><source>J Antibiot</source><volume>72</volume><year>2019</year><fpage>181</fpage><lpage>184</lpage></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Morshed</surname><given-names>M.T.</given-names></name><name><surname>Nguyen</surname><given-names>H.T.</given-names></name><name><surname>Vuong</surname><given-names>D.</given-names></name><name><surname>Crombie</surname><given-names>A.</given-names></name><name><surname>Lacey</surname><given-names>E.</given-names></name><name><surname>Ogunniyi</surname><given-names>A.D.</given-names></name><etal/></person-group><article-title>Semisynthesis and biological evaluation of a focused library of unguinol derivatives as next-generation antibiotics</article-title><source>Org Biomol Chem</source><volume>19</volume><year>2021</year><fpage>1022</fpage><lpage>1036</lpage><pub-id pub-id-type="pmid">33443509</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>J.J.</given-names></name><name><surname>Craig</surname><given-names>J.W.</given-names></name><name><surname>Calle</surname><given-names>P.Y.</given-names></name><name><surname>Brady</surname><given-names>S.F.</given-names></name></person-group><article-title>Tailoring enzyme-rich environmental DNA clones: a source of enzymes for generating libraries of unnatural natural products</article-title><source>J Am Chem Soc</source><volume>132</volume><year>2010</year><fpage>15661</fpage><lpage>15670</lpage><pub-id pub-id-type="pmid">20945895</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K.</given-names></name><name><surname>Shaw</surname><given-names>S.</given-names></name><name><surname>Kloosterman</surname><given-names>A.M.</given-names></name><name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name><name><surname>Medema</surname><given-names>M.H.</given-names></name><etal/></person-group><article-title>antiSMASH 6.0: improving cluster detection and comparison capabilities</article-title><source>Nucleic Acids Res</source><volume>49</volume><year>2021</year><fpage>W29</fpage><lpage>W35</lpage><pub-id pub-id-type="pmid">33978755</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.Y.</given-names></name><name><surname>Cai</surname><given-names>C.L.</given-names></name><name><surname>Yang</surname><given-names>J.F.</given-names></name><name><surname>Shi</surname><given-names>J.J.</given-names></name><name><surname>Song</surname><given-names>Y.X.</given-names></name><name><surname>Hu</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Development of the CRISPR-Cas9 system for the marine-derived fungi <italic>Spiromastix</italic> sp. SCSIO F190 and <italic>Aspergillus</italic> sp. SCSIO SX7S7</article-title><source>J Fungi</source><volume>8</volume><year>2022</year><fpage>715</fpage><lpage>729</lpage></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>Y.M.</given-names></name><name><surname>Lin</surname><given-names>T.S.</given-names></name><name><surname>Wang</surname><given-names>C.C.C.</given-names></name></person-group><article-title>Total heterologous biosynthesis of fungal natural products in <italic>Aspergillus nidulans</italic></article-title><source>J Nat Prod</source><volume>85</volume><year>2022</year><fpage>2484</fpage><lpage>2518</lpage><pub-id pub-id-type="pmid">36173392</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>C.</given-names></name><name><surname>Wei</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>C.H.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name></person-group><article-title>Biosynthesis of diphenyl ethers in fungi</article-title><source>Org Lett</source><volume>21</volume><year>2019</year><fpage>3114</fpage><lpage>3118</lpage><pub-id pub-id-type="pmid">30990700</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Seibert</surname><given-names>C.M.</given-names></name><name><surname>Raushel</surname><given-names>F.M.</given-names></name></person-group><article-title>Structural and catalytic diversity within the amidohydrolase superfamily</article-title><source>Biochemistry-Us</source><volume>44</volume><year>2005</year><fpage>6383</fpage><lpage>6391</lpage></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>C.L.</given-names></name><name><surname>Yang</surname><given-names>J.F.</given-names></name><name><surname>Shi</surname><given-names>J.J.</given-names></name><name><surname>Song</surname><given-names>Y.X.</given-names></name><name><surname>Hu</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Mechanism and structure of <italic>&#x003b3;</italic>-resorcylate decarboxylase</article-title><source>Biochemistry</source><volume>57</volume><year>2018</year><fpage>3167</fpage><lpage>3175</lpage><pub-id pub-id-type="pmid">29283551</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Hult</surname><given-names>K.</given-names></name><name><surname>Berglund</surname><given-names>P.</given-names></name></person-group><article-title>Enzyme promiscuity: mechanism and applications</article-title><source>Trends Biotechnol</source><volume>25</volume><year>2007</year><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">17379338</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Khersonsky</surname><given-names>O.</given-names></name><name><surname>Tawfik</surname><given-names>D.S.</given-names></name></person-group><article-title>Enzyme promiscuity: a mechanistic and evolutionary perspective</article-title><source>Annu Rev Biochem</source><volume>79</volume><year>2010</year><fpage>471</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">20235827</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>B.R.K.</given-names></name><name><surname>Brandenburger</surname><given-names>E.</given-names></name><name><surname>Sharif</surname><given-names>H.H.</given-names></name><name><surname>Klemstein</surname><given-names>U.</given-names></name><name><surname>Shepherd</surname><given-names>S.A.</given-names></name><name><surname>Greaney</surname><given-names>M.F.</given-names></name><etal/></person-group><article-title>RadH: a versatile halogenase for integration into synthetic pathways</article-title><source>Angew Chem Int Ed Engl</source><volume>56</volume><year>2017</year><fpage>11841</fpage><lpage>11845</lpage><pub-id pub-id-type="pmid">28722773</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Tsunematsu</surname><given-names>Y.</given-names></name><name><surname>Maeda</surname><given-names>N.</given-names></name><name><surname>Yokoyama</surname><given-names>M.</given-names></name><name><surname>Chankhamjon</surname><given-names>P.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Scherlach</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Enzymatic amide tailoring promotes retro-aldol amino acid conversion to form the antifungal agent aspirochlorine</article-title><source>Angew Chem Int Ed Engl</source><volume>57</volume><year>2018</year><fpage>14051</fpage><lpage>14054</lpage><pub-id pub-id-type="pmid">30109903</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Spyrou</surname><given-names>G.</given-names></name><name><surname>Haggard-Ljungquist</surname><given-names>E.</given-names></name><name><surname>Krook</surname><given-names>M.</given-names></name><name><surname>Jornvall</surname><given-names>H.</given-names></name><name><surname>Nilsson</surname><given-names>E.</given-names></name><name><surname>Reichard</surname><given-names>P.</given-names></name></person-group><article-title>Characterization of the flavin reductase gene (<italic>fre</italic>) of <italic>Escherichia coli</italic> and construction of a plasmid for overproduction of the enzyme</article-title><source>J Bacteriol</source><volume>173</volume><year>1991</year><fpage>3673</fpage><lpage>3679</lpage><pub-id pub-id-type="pmid">2050627</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.K.</given-names></name><name><surname>Zang</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>S.G.</given-names></name><name><surname>Bat-Erdene</surname><given-names>U.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Resistance-gene-directed discovery of a natural-product herbicide with a new mode of action</article-title><source>Nature</source><volume>559</volume><year>2018</year><fpage>415</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">29995859</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Zang</surname><given-names>X.</given-names></name><name><surname>Jamieson</surname><given-names>C.S.</given-names></name><name><surname>Lin</surname><given-names>H.C.</given-names></name><name><surname>Houk</surname><given-names>K.N.</given-names></name><name><surname>Zhou</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>Biosynthesis of the fungal glyceraldehyde-3-phosphate dehydrogenase inhibitor heptelidic acid and mechanism of self-resistance</article-title><source>Chem Sci</source><volume>11</volume><year>2020</year><fpage>9554</fpage><lpage>9562</lpage><pub-id pub-id-type="pmid">34094220</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Nodvig</surname><given-names>C.S.</given-names></name><name><surname>Nielsen</surname><given-names>J.B.</given-names></name><name><surname>Kogle</surname><given-names>M.E.</given-names></name><name><surname>Mortensen</surname><given-names>U.H.</given-names></name></person-group><article-title>A CRISPR-Cas9 system for genetic engineering of filamentous fungi</article-title><source>PLoS One</source><volume>10</volume><year>2015</year><object-id pub-id-type="publisher-id">e0133085</object-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.F.</given-names></name><name><surname>Song</surname><given-names>Y.X.</given-names></name><name><surname>Tang</surname><given-names>M.C.</given-names></name><name><surname>Li</surname><given-names>M.Z.</given-names></name><name><surname>Deng</surname><given-names>J.W.</given-names></name><name><surname>Wong</surname><given-names>N.K.</given-names></name><etal/></person-group><article-title>Genome-directed discovery of tetrahydroisoquinolines from deep-sea derived <italic>Streptomyces niveus</italic> SCSIO 3406</article-title><source>J Org Chem</source><volume>86</volume><year>2021</year><fpage>11107</fpage><lpage>11116</lpage><pub-id pub-id-type="pmid">33770435</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0215">The following is the Supplementary data to this article.<supplementary-material content-type="local-data" id="mmc1"><caption><title>Multimedia component 1</title></caption><media xlink:href="mmc1.pdf"><alt-text>Multimedia component 1</alt-text></media></supplementary-material></p></sec><fn-group><fn id="d35e410"><p id="ntpara0010">Peer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.</p></fn><fn id="appsec2" fn-type="supplementary-material"><label>Appendix A</label><p id="p0220">Supporting data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.apsb.2023.05.036" id="intref0015">https://doi.org/10.1016/j.apsb.2023.05.036</ext-link>.</p></fn></fn-group></back></article>